Jonathan Swingle, The Mucosal Melanoma Warrior
…never heard the term mucosal melanoma. His lack of knowledge is not surprising, as mucosal melanoma is extremely rare, accounting…
Jonathan Swingle, The Mucosal Melanoma Warrior
…never heard the term mucosal melanoma. His lack of knowledge is not surprising, as mucosal melanoma is extremely rare, accounting…
,
Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor
…doctor had never seen in her 18 years of practice: vaginal mucosal melanoma. Mucosal melanoma accounts for about 1.4% of…
,
Medical Advisory Board
…Kashani-Sabet UCSF Cancer Center, U.S.A Dr. John Kirkwood UPMC Hillman Cancer Center, U.S.A Dr. Sancy Leachman OHSU, U.S.A. Dr. Georgina…
Alabama
[aim_melanoma_specialist] Find a Specialist University of Alabama at Birmingham Comprehensive Cancer Center * 2145 Bonner Way Birmingham, AL 35243 205-934-5077…
Alaska
[aim_melanoma_specialist] Unfortunately, we have no specialists listed for this state. Please check another state for a list of specialists who…
Arkansas
[aim_melanoma_specialist] Find a Specialist Winthrop Paul Rockefeller Cancer Institute University of Arkansas 4301 West Markham St. Little Rock, AR 72205…
Canada: Ontario
[aim_melanoma_specialist] Find a Specialist Royal Victoria Hospital of Barrie Oncology Dept. 201 Georgian Dr. Barrie, Ontario L4M 6M2 705-739-5661 rvh.on.ca…
Missouri
[aim_melanoma_specialist] Find a Specialist Siteman Cancer Center * Barnes-Jewish Hospital and Washington University Medical School 4921 Parkview Ave. St. Louis,…
South Carolina
[aim_melanoma_specialist] Find a Specialist MUSC Hollings Cancer Center 86 Jonathan Lucas St Charleston, SC 29425 843-792-9300 hcc.musc.edu Theodore Gourdin, MD…
Ways to Raise Funds
Ways to Raise Funds Are you passionate about finding the cure for melanoma? So are we. Let’s work together. We’ve…
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026